Nemucore Study Published in Molecular Pharmaceutics Furthers Understanding of NMI-350 and Theranostics for Ovarian Cancer
23 mai 2016 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 23, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a clinical-stage biopharmaceutical company dedicated to the development of therapies targeting highly...
Nemucore Medical Innovations Announces Appointment of Nicholas De Monico to its Board of Directors
16 mai 2016 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 16, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies targeting...
Nemucore Medical Innovations Announces NMI-350 ACOG Poster Presentation
12 mai 2016 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 12, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces NMI-500 ACOG Poster Presentation
11 mai 2016 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., May 11, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations to Present at Needham & Company’s 15th Annual Healthcare Conference
05 avr. 2016 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., April 05, 2016 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces Licensing Agreement With Pfenex Inc. Enabling Manufacture of Anti-Cancer Therapeutic NMI-8000, the Biologically Active Form of Mullerian Inhibitory Substance (MIS)
14 déc. 2015 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 14, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Announces Appointment of Dr. Michael V. Seiden to Its Board of Directors and Clinical Advisory Board
09 déc. 2015 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 09, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Options Clinical-Stage Aurora Kinase Inhibitor GSK1070916 From Cancer Research Technology (CRT)
07 déc. 2015 08h10 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...
Nemucore Medical Innovations Completes Series A Financing
07 déc. 2015 08h05 HE
|
Nemucore Medical Innovations, Inc.
WORCESTER, Mass., Dec. 07, 2015 (GLOBE NEWSWIRE) -- Nemucore Medical Innovations, Inc., a privately held, clinical-stage biopharmaceutical company dedicated to the development of therapies...